Human immunodeficiency virus enhances hepatitis C virus replication by differential regulation of IFN and TGF family genes

Journal of Medical Virology

Volumn 84, Issue 9, 2012, Pages 1344-1352

  Zhang, Xiaozhen ^a   Daucher, Marybeth ^a   Baeza, Josue ^a   Kim, Cheol Woo ^a   Russell, Rodney ^b   Kottilil, Shyamasundaran ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

CD4; Co infection; HCV; HIV; Pathogenesis

Indexed keywords

CD4 ANTIGEN; INTERFERON; TRANSFORMING GROWTH FACTOR BETA; VIRUS RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENETIC REGULATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; LIVER CELL CARCINOMA; MIXED INFECTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROVIRUS; UPREGULATION; VIRUS REPLICATION;

ANTIGENS, CD4; CELL LINE, TUMOR; COINFECTION; GENE EXPRESSION REGULATION; HEPACIVIRUS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERONS; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TRANSFORMING GROWTH FACTORS; VIRUS REPLICATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84864132392     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23315     Document Type: Article

References (42)

1. Blackard JT, Sherman KE. 2008. HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver? J Viral Hepat 15: 323-330.
2. Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccala G, Chung RT. 2006. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol 78: 202-207.
3. Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT. 2007. Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res 27: 263-269.
4. Blight KJ, McKeating JA, Marcotrigiano J, Rice CM. 2003. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77: 3181-3190.
5. Blobe GC, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
6. Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. 1992. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS 6: 65-70.
7. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. 1998. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 95: 8869-8873.
8. Fabregat I, Roncero C, Fernandez M. 2007. Survival and apoptosis: A dysregulated balance in liver cancer. Liver Int 27: 155-162.
9. Feng XH, Derynck R. 2005. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693.
10. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. 2001. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis 33: 562-569.
11. Hayashi H, Sakai T. 2012. Biological significance of local TGF-beta activation in liver diseases. Front Physiol 3: 12.
12. Herrera B, Alvarez AM, Beltran J, Valdes F, Fabregat I, Fernandez M. 2004. Resistance to TGF-beta-induced apoptosis in regenerating hepatocytes. J Cell Physiol 201: 385-392.
13. Housset C, Lamas E, Brechot C. 1990. Detection of HIV1 RNA and p24 antigen in HIV1-infected human liver. Res Virol 141: 153-159.
14. Huang DW, Sherman BT, Lempicki RA. 2009a. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
15. Huang DW, Sherman BT, Lempicki RA. 2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
16. Ikeda S, Mitaka T, Harada K, Sugimoto S, Hirata K, Mochizuki Y. 2002. Proliferation of rat small hepatocytes after long-term cryopreservation. J Hepatol 37: 7-14.
17. Katze MG, He Y, Gale M, Jr. 2002. Viruses and interferon: A fight for supremacy. Nat Rev Immunol 2: 675-687.
18. Kim AY, Chung RT. 2009. Coinfection with HIV-1 and HCV-A one-two punch. Gastroenterology 137: 795-814.
19. Levy DE, Garcia-Sastre A. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12: 143-156.
20. Lin W, Weinberg EM, Tai AW, Peng LF, Brockman MA, Kim KA, Kim SS, Borges CB, Shao RX, Chung RT. 2008. HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology 134: 803-811.
21. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
22. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
23. Monga HK, Rodriguez Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, Yoffe B. 2001. Hepatitis C virus infection related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 33: 240-247.
24. Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE. 2003. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 188: 1192-1204.
25. Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R. 2002. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76: 4008-4021.
26. Pokrovskii MV, Bush CO, Beran RK, Robinson MF, Cheng G, Tirunagari N, Fenaux M, Greenstein AE, Zhong W, Delaney WEt, Paulson MS. 2011 Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics. J Virol 85: 3978-3985.
27. Roe B, Hall WW. 2008. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Expert Rev Mol Med 10: e30.
28. Rotman Y, Liang TJ. 2009. Coinfection with hepatitis C virus and human immunodeficiency virus: Virological, immunological, and clinical outcomes. J Virol 83: 7366-7374.
29. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
30. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
31. Selik RM, Byers RH, Jr., Dworkin MS. 2002. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 29: 378-387.
32. Sherman KE, Rouster SD, Chung RT, Rajicic N. 2002. Hepatitis C Virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group. Clin Infect Dis 34: 831-837.
33. Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M. 2008. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: A 20-year prospective study. J Acquir Immune Defic Syndr 47: 221-225.
34. Sulkowski MS, Thomas DL. 2003. Hepatitis C in the HIV-infected person. Ann Intern Med 138: 197-207.
35. ten Dijke P, Arthur HM. 2007. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8: 857-869.
36. Trembley JH, Chen Z, Unger G, Slaton J, Kren BT, Van Waes C, Ahmed K. 2010. Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors 36: 187-195.
37. Tuyama AC, Hong F, Saiman Y, Wang C, Ozkok D, Mosoian A, Chen P, Chen BK, Klotman ME, Bansal MB. 2010. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 52: 612-622.
38. Verrecchia F, Wagner EF, Mauviel A. 2002. Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Rep 3: 1069-1074.
39. Vlahakis SR, Villasis-Keever A, Gomez TS, Bren GD, Paya CV. 2003. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J Infect Dis 188: 1455-1460.
40. Wakefield LM, Stuelten C. 2007. Keeping order in the neighborhood: New roles for TGFbeta in maintaining epithelial homeostasis. Cancer Cell 12: 293-295.
41. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
42. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102: 9294-9299.